Spectrus
Enrique Arevalo is a seasoned expert in the field of biochemistry, biophysics, and molecular biology, currently serving as the Co-Founder and Chief Scientific Officer at Spectrus LLC since November 2017, where meticulous attention to scientific inquiries supports biotech clients. Prior experience includes a role as Principal Scientist at Momenta from April 2007 to November 2017, leading predictive modeling teams for disease and treatment biomarker discovery. Enrique's earlier positions include Senior Research Scientist at Northeastern University specializing in biomarker discovery from breast cancer tissue, and postdoctoral research at both Massachusetts General Hospital and Harvard Medical School, where significant work on the serotonin (5HT3R) receptor was conducted. Educational qualifications include a PhD in Biochemistry, Biophysics, and Molecular Biology from The City University of New York and a Bachelor's degree in Chemistry from Pontificia Universidad Católica del Perú.
This person is not in any teams
This person is not in any offices
Spectrus
At Spectrus, we are dedicated to accelerating the discoveries of life science companies through mass spectrometry. Our vision is that the expert services we offer as a contract research organization will catalyze scientific advancements that address the most pressing health and environmental challenges of our time. These advancements will pave the way for a brighter future and enhanced quality of life for all. Our commitment to excellence and accuracy is reflected in every aspect of our service: - Proactive Communication throughout every step of the process to foster collaboration - Tailored Method Design to fit the unique specifications of your project - Efficient and Accurate Sample Processing by leveraging our advanced technologies and expertise - Insightful Data Interpretation so your team obtains actionable results to make informed decisions Visit our website to learn more about our offerings and commitment to client satisfaction.